Skip to content

Prospective study to evaluate clinico-mycological profile and antifungal drug susceptibility in dermatophytic skin infections

Prospective study to evaluate clinico-mycological profile and antifungal drug susceptibility in dermatophytic skin infections

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2018/02/011988
Enrollment
40
Registered
2018-02-19
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Tinea corporis and cruris

Interventions

None listed

Sponsors

NONE
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Forty consenting adult patients with a diagnosis of Tinea cruris and/or corporis, on clinical examination with confirmation by KOH microscopy, who would require systemic treatment as per the assessment of the examining physician and have at least 5 cutaneous lesions shall be included.

Exclusion criteria

Exclusion criteria: 1. Patients who have used any systemic antifungal therapy within the preceding 4 weeks and any topical treatment (antifungals/steroids/combination of the 2) in the preceding 2 weeks shall be excluded. 2. Pregnant/lactating women

Design outcomes

Primary

MeasureTime frame
1. Knowing the clinic-mycological profile of patients with Tinea cruris and corporis. 2.Determining the antifungal sensitivity profiles of the isolated dermatophytes from patients. 3.Correlation of the clinical response with standard antifungal treatment, with mycological profile and drug sensitivity patterns. Timepoint: BY 1ST MARCH 2018

Secondary

MeasureTime frame
Clinical correlation of MIC dataTimepoint: BY 1ST MARCH 2018

Countries

India

Contacts

Public ContactAnanta Khurana

Dr RML hospital and PGIMER

drananta2014@gmail.com9212370467

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026